AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
17,356,611
Share change
-4,047,030
Total reported value
$45,966,000
Put/Call ratio
101%
Price per share
$2.65
Number of holders
43
Value change
-$56,823,834
Number of buys
28
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q2 2018

As of 30 Jun 2018, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,356,611 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, EcoR1 Capital, LLC, Prosight Management, LP, DLD Asset Management, LP, VANGUARD GROUP INC, BlackRock Inc., HIGHBRIDGE CAPITAL MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., and UNIVERSITY OF NOTRE DAME DU LAC. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.